Address: Av. Nações Unidas, 22215 – Alto de Pinheiros São Paulo, 04795-100
Tel: +55 11 5090.8487
In 1972, Eurofarma started its path manufacturing drugs to third parties, national and international laboratories. As the years went by and with the increase of market perception, production capacity, equipment technology and the strict quality control adopted, the company grew. It acquired new companies and started to manufacture and market its own brands and under multinational license.
It is currently the third greatest national capital
pharmaceutical group in Brazil and, according to Grupemef (Group of Pharmaceutical Industry Executive Professionals),
it is one of the five greatest pharmaceutical laboratories in the country. It produces and markets drugs for human and veterinary use, by means of eight business divisions: Pharma (Medical Prescription), Hospital, Generic Drugs, Oncology, Pearson (Veterinary), Third Parties, Export, and Euroglass. Thus, it has a complete line of products which cover several pathologies, acting both in the fight and prevention against various diseases.
The year 2008 was decisive to Eurofarma’s evolution. We were able to maintain our essence, based on ethics, hard work and our product’s quality. At the same time, we made progress on strategic issues, developing actions and establishing partnerships that bring us closer to our Vision.
We commenced the development of clinical trials in this Country for innovative drugs in the Oncology field, being pioneers in the participation of a national industry in a worldwide partnership.
Also in 2008 we opened the Hormones Block in Itapevi Complex. Close to the conclusion of the construction, the following steps are: to open the Oncology and Solid Blocks (the last one being the main Block of the complex) in 2009 and the Injectable Block in 2010. After this process we will centralize the main productive activities of this company in only one place, which provides the proper infra-structure in order to meet the needs of the internal market and to go on with the internationalization project.
Products and services
Innovative prescription, branded generics, and generics